- Home
- ASC vs XOMA Comparison
ASC vs XOMA Comparison
Compare ASC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- XOMA
- Stock Information
- Founded
- ASC 2010
- XOMA 1981
- Country
- ASC Bermuda
- XOMA United States
- Employees
- ASC N/A
- XOMA N/A
- Industry
- ASC Marine Transportation
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- ASC Consumer Discretionary
- XOMA Health Care
- Exchange
- ASC Nasdaq
- XOMA Nasdaq
- Market Cap
- ASC 399.7M
- XOMA 330.2M
- IPO Year
- ASC 2013
- XOMA N/A
- Fundamental
- Price
- ASC $10.22
- XOMA $25.83
- Analyst Decision
- ASC Buy
- XOMA Strong Buy
- Analyst Count
- ASC 3
- XOMA 2
- Target Price
- ASC $13.67
- XOMA $69.50
- AVG Volume (30 Days)
- ASC 555.9K
- XOMA 59.0K
- Earning Date
- ASC 07-30-2025
- XOMA 08-12-2025
- Dividend Yield
- ASC 9.30%
- XOMA N/A
- EPS Growth
- ASC N/A
- XOMA N/A
- EPS
- ASC 2.30
- XOMA N/A
- Revenue
- ASC $373,479,000.00
- XOMA $42,909,000.00
- Revenue This Year
- ASC N/A
- XOMA $70.91
- Revenue Next Year
- ASC N/A
- XOMA $14.00
- P/E Ratio
- ASC $4.49
- XOMA N/A
- Revenue Growth
- ASC N/A
- XOMA 638.41
- 52 Week Low
- ASC $8.32
- XOMA $18.35
- 52 Week High
- ASC $22.70
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- ASC 53.07
- XOMA 48.34
- Support Level
- ASC $9.90
- XOMA $25.42
- Resistance Level
- ASC $10.53
- XOMA $26.63
- Average True Range (ATR)
- ASC 0.30
- XOMA 0.89
- MACD
- ASC 0.01
- XOMA -0.19
- Stochastic Oscillator
- ASC 54.55
- XOMA 12.50
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.